EUVIMEDEUVIMED entdecken
Crossref

Photoresponsive and Shape-Switchable MoS 2 –Peptide-Hybrid Nanosystems for Enacting Photochemo and siRNA-Mediated Gene Therapy in Glioma

Sonika Chibh, Nidhi Aggarwal, Neelam Gupta, Shahjad Ali iD, Jibanananda Mishra iD, Siddharth Tiwari, Md Ehesan Ali iD, Durga Prasad Mishra, Jiban Jyoti Panda iD

ACS Applied Materials & Interfaces · 21.05.2025 · 17 (20) · 29318-29340

DOI: 10.1021/acsami.5c03616 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 09.05.2025. Verfasst von Sonika Chibh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Biology Unit, Institute of Nano Science and Technology, Sector-81, Mohali, Punjab 140306, India. Hauptthemen laut MEDLINE: Glioma, RNA, Small Interfering, Disulfides, Molybdenum. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Indian Council of Medical Research, Council of Scientific and Industrial Research, India, Science and Engineering Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Exfoliated 2D transition-metal dichalcogenide (TMDCs)-based nanomaterials have captured a huge biomedical territory owing to their supreme physicochemical properties. However, the tedious and harsh chemical exfoliation of bulk MoS2 impacts its utility in the biological domain. The study introduces a facile and environmentally benign way of shape-tunable exfoliation of bulk MoS2 materials in an aqueous dispersion using designed self-assembled, tetrapeptide (Fmoc-HCKF-OH)-based nanostructures, generating hybrid MoS2-peptide nanosystems for both tumor-targeted [employing folic acid (FA) functionalization] and NIR-responsive delivery of anticancer siRNA/drug in glioma. Exfoliated MoS2-peptide NSs here prove to be an excellent photothermal agent by inducing a temperature elevation upto ∼51 °C upon 808 nm NIR absorption. Enhanced siRNA/Dox loading onto the 2D flat morphology of MoS2-peptide NSs resulted in ∼90% cancer cell death in C6 glioma cells under NIR exposure. The expression of the Galectin-1 oncogene was suppressed following the treatment. Thereafter, analysis in the C6 glioma syngeneic rat model demonstrated a significant reduction (>10 fold) in tumor volume with siRNA/Dox-loaded FA-MoS2-peptide NSs + NIR as compared to the phosphate buffer saline-treated control group. Further, in vivo biodistribution studies confirmed the higher targetability of FA-conjugated hybrid NSs. Taken together, our findings promote the utility of TMDC-based nanomaterials in conjecture with a biocompatible peptide scaffold as a trimodal chemo, gene, and phototherapeutic agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaRNA, Small InterferingDisulfidesMolybdenumGenetic TherapyPeptidesNanostructuresAnimalsRatsCell Line, TumorDoxorubicinHumansPhotochemotherapy

Stichwörter der Autor:innen

NIR irradiationanticancer siRNAexfoliated MoS2peptide nanostructuresphotothermal therapyshape-tunable

Substanzen

RNA, Small InterferingDisulfidesMolybdenummolybdenum disulfidePeptidesDoxorubicin

Autor:innen und Institutionen

  • Chemical Biology Unit, Institute of Nano Science and Technology, Sector-81, Mohali, Punjab 140306, India.
  • Division of Endocrinology, CSIR-Central Drug Research Institute, Sector-10, Jankipuram extension, Lucknow 226031, India.
  • Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh 201002, India.
  • Quantum Materials and Devices Unit, Institute of Nano Science and Technology, Sector-81, Mohali, Punjab 140306, India.
  • School of Basic, Applied and Biosciences, RIMT University, Mandi-Gobindgarh, Punjab 147301, India.
  • BRIC-National Agri-Food and Biomanufacturing Institute (BRIC-NABI) (Formerly National Agri-Food Biotechnology Institute), Department of Biotechnology, Ministry of Science and Technology (Government of India), Sector-81,…

ORCID-Profile: Shahjad Ali, Jibanananda Mishra, Md Ehesan Ali, Jiban Jyoti Panda

Förderung

  • Indian Council of Medical Research
  • Council of Scientific and Industrial Research, India
  • Science and Engineering Research Board
  • Department of Biotechnology, Ministry of Science and Technology, India

Zitieren

APA

Chibh, S., Aggarwal, N., Gupta, N., Ali, S., Mishra, J., Tiwari, S., Ali, M. E., Mishra, D. P., & Panda, J. J. (2025). Photoresponsive and Shape-Switchable MoS 2 –Peptide-Hybrid Nanosystems for Enacting Photochemo and siRNA-Mediated Gene Therapy in Glioma. ACS Applied Materials & Interfaces, 17(20), 29318-29340. https://doi.org/10.1021/acsami.5c03616

Vancouver

Chibh S, Aggarwal N, Gupta N, Ali S, Mishra J, Tiwari S, et al. Photoresponsive and Shape-Switchable MoS 2 –Peptide-Hybrid Nanosystems for Enacting Photochemo and siRNA-Mediated Gene Therapy in Glioma. ACS Applied Materials & Interfaces. 2025;17(20):29318-29340. doi:10.1021/acsami.5c03616

BibTeX
@article{Chibh2025,
  author = {Chibh, Sonika and Aggarwal, Nidhi and Gupta, Neelam and Ali, Shahjad and Mishra, Jibanananda and Tiwari, Siddharth and Ali, Md Ehesan and Mishra, Durga Prasad and Panda, Jiban Jyoti},
  title = {Photoresponsive and Shape-Switchable MoS 2 –Peptide-Hybrid Nanosystems for Enacting Photochemo and siRNA-Mediated Gene Therapy in Glioma},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  volume = {17},
  number = {20},
  pages = {29318--29340},
  doi = {10.1021/acsami.5c03616}
}
Kostenlos starten →